全踝关节置换术后假体周围骨溶解的自体骨移植结局:临床与三维CT结果
回顾性分析42例全踝关节置换术后假体周围骨溶解行自体骨移植的踝关节,临床评分显著改善,骨溶解囊肿体积由4.8 cm³降至0.8 cm³;假体生存率5年100%、10年85.7%,但无再手术生存率5年93.4%、10年68.4%,低于无骨溶解或无进展性骨溶解者。作者认为自体骨移植联合连续CT监测可能延长假体生存。
要点
- 全踝关节置换术后假体周围骨溶解行自体骨移植后临床评分显著改善。
- 骨溶解囊肿平均体积由术前4.8 cm³改善至末次随访0.8 cm³。
- 骨移植后假体生存10年85.7%,但无再手术生存10年仅68.4%。
核心结论
- 全踝关节置换术后假体周围骨溶解行自体骨移植可获得良好的临床与影像学结果。
- 即使骨移植成功,与无骨溶解或无进展性骨溶解的全踝关节置换相比,后续手术风险仍更高。
- 作者认为自体骨移植联合连续CT扫描监测可能延长假体周围骨溶解踝关节的假体生存期。
研究设计与样本
- 回顾性研究,纳入42例踝关节(41例韩国患者),均因全踝关节置换术后假体周围骨溶解行自体骨移植。
- 临床结局采用疼痛视觉模拟评分、踝关节骨关节炎量表疼痛与功能障碍评分及美国足踝外科协会踝-后足量表评分评估。
- 术前及术后至少2年行CT检查以评估治疗反应,并评估组织学、假体生存率、再手术与并发症。
主要发现
- 自体骨移植的平均时间为术后64.4个月(范围10至128个月),骨移植后平均随访70.7个月(范围24至137个月)。
- 所有临床评分从术前至末次随访均显著改善。
- 平均骨溶解囊肿体积从4.8 cm³(范围1.1至19.4 cm³)改善至0.8 cm³(范围0至6.5 cm³)。
- Kaplan-Meier生存分析显示,全踝关节置换后行骨移植的假体生存率5年为100%、10年为85.7%。
- 全踝关节置换后行骨移植的无再手术生存率5年为93.4%、10年为68.4%,低于无骨溶解或无进展性骨溶解的全踝关节置换。
关键数值与推荐
- 平均骨溶解囊肿体积从4.8 cm³(范围1.1至19.4 cm³)改善至0.8 cm³(范围0至6.5 cm³)。
- 假体生存率5年为100%、10年为85.7%。
- 无再手术生存率5年为93.4%、10年为68.4%。
- 证据等级为治疗性IV级。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periprosthetic osteolysis after total ankle arthroplasty (TAA) is a substantial problem. Bone grafting may be beneficial in the treatment of large osteolytic cysts; however, the literature regarding the outcomes of bone grafting is limited. This study analyzed the outcomes of autogenous bone grafting performed for the management of periprosthetic osteolysis following TAA. METHODS: We retrospectively reviewed 42 ankles (41 Korean patients) that underwent autogenous bone grafting for periprosthetic osteolysis following TAA. Clinical outcomes were evaluated using visual analog scale for pain scores, Ankle Osteoarthritis Scale pain and disability scores, and American Orthopaedic Foot & Ankle Society Ankle-Hindfoot Scale scores. Computed tomography (CT) was performed preoperatively and for at least 2 years postoperatively in order to evaluate the treatment response. Histology, prosthesis survivorship, reoperations, and complications were also evaluated. RESULTS: The mean time to autogenous bone grafting was 64.4 months (range, 10 to 128 months), and the mean follow-up duration after autogenous bone grafting was 70.7 months (range, 24 to 137 months). All clinical scores significantly improved from preoperatively to the last follow-up visit. The mean osteolytic cyst volume improved from 4.8 cm 3 (range, 1.1 to 19.4 cm 3 ) to 0.8 cm 3 (range, 0 to 6.5 cm 3 ). A Kaplan-Meier survival analysis revealed that TAA with subsequent bone grafting was associated with similar prosthesis survivorship (100% and 85.7% at 5 and 10 years, respectively) but inferior reoperation-free survivorship (93.4% and 68.4% at 5 and 10 years, respectively) compared with TAA without osteolysis or with non-progressive osteolysis. CONCLUSIONS: Autogenous bone grafting performed for the management of periprosthetic osteolysis after TAA produced favorable clinical and radiographic outcomes. However, there was still a higher risk of subsequent surgery even after successful bone grafting, compared with TAA without osteolysis or with non-progressive osteolysis. Our results suggest that autogenous bone grafting and serial CT scan monitoring over time may prolong the survivorship of TAA prostheses in ankles with periprosthetic osteolysis. LEVEL OF EVIDENCE: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
引用
- Yoon YK, Park KH, Shim DW, et al. Outcomes of Autogenous Bone Grafting for Periprosthetic Osteolysis After Total Ankle Arthroplasty: Clinical and 3-Dimensional Computed Tomography Results. J Bone Joint Surg Am. 2025. PMID: 39999208. doi:10.2106/JBJS.24.00580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。